AA Nontumored Animals (Toxicity Test)
AC Carcinoma Adrenal Cortex (No. 2)
AD ADJ-PC-22 Plasma Cell
AG L1210 Leukemia/8-Azaguanine; NSC 749
AK Lymphoma AKR (Transplanted)
AM Amelanotic Melanoma (No. 4)
AS Rat AC Glioma
A2 ADJ-PC-20 Plasma Cell
A3 Lieberman Plasma Cell No. 1 (LPC-1)
A5 ADJ-PC-5 Plasma Cell
A6 ADJ-PC-6
BA Clone Derived Amelanotic B16
BC L1210 Leukemia/BCNU; NSC 409962
BM Clone Derived Melanotic B16
BP P388 Leukemia/BCNU: NSC 409962
B1 B16 Melanoma
CA Adenocarcinoma 755
CB **missing value**
CD Mammary Adenocarcinoma CD8F1
CH Chang Liver (Cell Culture)
CL NCI-H460 Large Cell Carcinoma of the Lung
CM Dunning Leukemia/Mitomycin C; NSC 26980 (Solid)
CP P388 Leukemia/Cis DDPT: NSC 119875
CR L1210 Leukemia/Cytocan & Ara-C; NSC 26271 NSC 33878
CS Dunning Leukemia/Cycloleucine
CX L1210 Leukemia/Cytoxan; NSC 26271
CY Colon 36
CZ Colon 51
C2 HT29 : CX-1 Human Adenocarcinoma (MER+)
C3 C3H Mammary Tumor
C4 CX-2 Colon Xenograft
C5 CX-3 Colon Xenograft
C6 Colon 26 Adenocarcinoma
C7 CX-4 Colon Xenograft
C8 Colon Carcinoma 38
C9 CX-5 Colon Xenograft
DA Dunning Leukemia (Ascites) (See DL)
DH Dunning Leukemia/HexamethyImelamine; NSC 13875
DL Dunning Leukemia (Ascitic)
DM DMBA Induced Mammary Adenocarcinoma
DN Dunning Leukemia/A Nitrogen Mustard; NSC 51845 (Solid)
DP L1210 Leukemia/Cisplatin II; NSC 119875
DR Dunning Leukemia/A Thiopurine: NSC 29189 (Ascitic)
DX Dunning Leukemia/Cytoxan; NSC 26271 (Ascitic)
D1 Adenocarcinoma. Duodenum (Hamster & Cell Culture)
EA Ehrlich Ascites Tumor
EC B-Galactoside Phage
EM Ependymoblastoma
EN Adenocarcinoma, Endometrium
EP Ependymoblastoma
FM Friend Virus Erythroleukeima Ascites (P. Marks Line DS-19)
FR P815/5-Fluorouridine: NSC 27640 (Ascitic)
FS Fibrosarcoma (No 2)
FU P815/5-Fluorouracil; NSC 19893 (Ascitic)
FV Friend Virus Leukemia (Solid)
GA Lymphosarcoma Gardner 6C3HED
GE Adl Gardner 6C3HED Lymphosarcoma/l-Asparaginase: NSC 109229
GL Lymphosarcoma LePage Gardner 6C3HED Sensitive to Ara-A: NSC 404241
G1 Lymphosarcoma LePage Gardner 6C3HED Sensitive to Ara-A: NSC 404241 **missing**
GS 239PU-Induced Osteogenic Sarcoma
Gl Glioma 261
G2 Glioma 26
HD Hepatoma 134
HE Hepatoma 129 (Mouse)
HE Cystadenocarcinoma.  Liver (No. 1) (Hamster)
HG Hep 2/2-Flouroadenine & 2-Fluoroadenosine; NSC 27364 NSC 30605 
HH HEP 2/6-MP & 6-Methylthiopurine Ribonucleoside & 2-Fluorodenine; NSC 755, NS 4911, NSC 27364
HL HL-60 Human Promvelocytic' Leukemia Xenograft
HM Hep 369; 2/6-Methylthiopurine Ribonucleoside: NSC 4911
HN NSC 755-Mus& SoMethylthiopur1ne Ribonucleoside; NSC 755, NSC 4911
HR Hep 2/6-Mercaptopurine; NSC 755
HU L1210 Leukemia/Hydroxyurea; NSC 32065 NSC 740
HX Hep 2/Methotrexate: NSC 740
H2 Hep 2 Human Epidermoid Carcinoma
H3 Hep 3 Human Epidermoid Carcinoma
IC L1210 Intracerebral Inoculation (See LE)
IC Dunning Leukimia Intracerebral Inoculation (See DL)
JA NCI-H23 Human Lung Adenocarcinoma
JB NCI-H324 Human Lung Adenocarcinoma
JC NCI-H522 Human Lung Adenocarcinoma
JD NCI-H125 Human Lung Adenosquamous Carcinema
JE NCI-H358 Human Lung Bronchiolo-Alyeolar, Carcinoma
JF NCI-H292 Human Lung Mucoepidermoid Carcinoma
JG **missing**
JH **missing**
JK **missing**
JM **missing**
JP **missing**
JV **missing**
JW **missing**
JX **missing**
JZ **missing**
KB Human Epidermoid Carcinoma of the Nasopharvnx (Cell Culture)
KC **missing**
KD **missing**
K4 AK4 Lymphoid Leukemia
LA L1210 Leukemia/Azacytidine; NSC 102816
LB L1210 Leukemia/BIC: NSC 82196
LC **missing**
LD **missing**
LE L1210 Leukemia
LF 11210 Leukemia/Methotrexate & Dichloromethotrexate: NSC 740. NSC 29630
LG L1210 Leukemia/Guanazole: NSC 1895
LH E1218 Leukemia/Cyclocytidine; NSC 145668
LJ L1210 Leukemia/L-Alanosine; NSC 153353
LK Human Lung LX-1 Xenograft
LL Lewis Lung Carcinoma
LM L1210 Leukemia/Dichloromethotrexate: NSC 29630
LN A549 Human Adenocarcioma of the Lung with characteristics of Type II Alveolar Epitheleial cells
LO Human Amelanotic Melanoma (LOX)
LP Liposarcoma (No. 1)
LQ L1210 Leukemia/Methane Sulfonate: NSC 102627
LR LI210 Leukemia/6-MMPR: NSC 40774
LS L1210 Leukemia/L-PAM: NSC 8806
LT Li2io Leukemia/Ftorafur; NSC 148958
LU L1210 Leukemia/5-Fluorouracil: NSC 19893
LV NCI-H322 Human Lung Bronchiolo-Alveolar Carcinoma
LW L1210 Leukemia/A Terephthalanilide NSZC 38280
LX L1210 Leukemia/Methotrexate; NSC 740
LY Lewis Lung Carcinoma/PALA NSC 224131
LX L1210 Leukemia/Methotrexate
L2 Lymphoma 2
L2 Leiomvosarcoma (No. 2)
L4 Lymphoma 4 
L8 Lymphoma 8
L8 15178Y Lymphatic Leukemia
L9 L5178Y Lymphatic Leukemia/L-Asparaginase: NSC 109229
MA 13762 Mammary Adenocarcinoma
MB Human Mammarv Carcinoma MX-i Xenograft
MC Adenocarcinoma. Breast
MD Madison 109 Lung Carcinoma
ME Lymphosarcoma Mecca
MF Human Breast MX-2 Xenograft
MG Human Breast MX-3 Xenograft
MH EMT6 Fibrosarcoma
ML L1210 Leukemia/Methy1-GAG; NSC 32946
MM Melanotic Melanoma
MP L1210 Leukemia/6-MP & 6-Thioguanine; NSC 755. NSC 752
MS Lymphosarcoma Murphy-Sturm
MT Human Mesothelioma
MX MXT Hormone Dependent Transplantable Mammary Adenocarciroma
MY Myeloid Leukemia in REM/UN Mouse
M2 MPC-2 Plasma Cell
M5 Sarcoma M5076
M6 M5076/Cisplatin II; NSC 119875
M7 Agrobacterium Tumetaciens Microbial Assay
M8 Candida Albicans Microbial Assay
M9 Zanthomona Compestris Microbial Assay
NH Novikoff Hepatoma
NL Nova Leukemia NRL-1871
NP Plasmacutoma No.  1/BCNU; NSC 409962
NR Neurilemmoma No. 1
OC Human Ovarian Carcinoma
OG Osteogenic Sarcoma
OS Osteogenic Sarcoma HE 10734
OT Human Ovarian Sarcoma
PA P388 Leukemia/Adriamydin; NSC 123127, Developed at Sr 08
PB P388 Leukemia/Daunomycin; NSC 8215l
PC P388 Leukemia/ARA-C: NSC 63878
PD P388 Leukemia/Actinomycin-D; NSC 3053
PE P388 Leukemia/AMSA; NSC 249992
PF P388 Leukemia/Dihydroxy Anthracenedione; NSC 299195
PG P388 Leukemia/DON; NSC 7365
PH P388 Leukemia/Acivicin NSC 163501
PJ P388/Bleomycin; NSC 125066
PK P388 Leukemia/Ellipticine; NSC 71795
PL P815/Vinblastine; NSC 49842
PM Plasmacytoma No.  !/Triethvlenemelamine: NSC 9706
PN Adenocarcinoma Pancreas No. 1
PO P388 Leukemia/Cytoxan NSC 26271
PP P388 Leukemia/L-PAM: NSC 8806
PQ P388 Leukemia Bristol Strain
PR Adenocarcinoma. Prostate
PS P388 Leukemia
PT Carcinoma, Pitutary
PU P388 Leukemia/5-Fluorouracil: NSC 19893
PV P388 Leukemia/Vincristine: NSC 67574
PW P388 Leukemia/A Terephthalanilide;NSC 38280
PX Plasmacytoma No. 1/Cytoxan; NSC 26271
PY PY89 Sarcoma
PZ P388 Leukemia/5-Azacytidine: NSC 102816
P1 Plasmacytoma No. 1
P2 P388 Leukemia/ARA-A & 2'-Deoxycoformycin: NSC 404241 NSC 218321 (ADL)
P3 P1534/Methotrexate: NSC 740
P4 P1534 Leukemia
P6 P388 Leukemia/L-Alanosine: NSC 153353
P7 P388 Leukemia/Methotrexate: NSC 740
P8 P815 Mast Cell Leukemia (Ascitic)
P9 P329 Reticulum Cell Sarcoma
RC Adenocarcinoma, Kidney
RE Renal Cell Carcinoma
RO Osteogenic Sarcoma Ridgway
RS Reticulum Cell Sarcoma (Kelley Mouse)
RS Reticulum Cell Lumphosarcoma No 5 (Hamster)
RX Ros/Cytoxan; NSC 26271
SA Sarcoma 180
SB Adenosarcoma Small Bowel (Ileum)
SC Human Tumor Colony Forming Assay
ST Special Testing Biochemical Assav (Host98)
TC L1210 Leukemia picolinaldhude.  Thiosemicarbazone NSC 779
TE TE-671 Human Meduloblastoma
TG Dunning Leukemia/Thioquanine Riboside NSC 79427
TR P388 eukemia/Tiazofurin: NSC 286193 Developed at Scr 08
UG U-251 Human Glioma
VA Colon Xenograft CS-1
VB **missing**
VE **missing**
VG BREAST XENOGRAFT BS-3
VH BREAST XENOGRAFT BS-4
VI LUNG XENOGRAFT LS-1
VJ PANCREAS XENOGRAFT PS -1
VK SARCOHA XENOGRAFT SS-1
VL SAPCOMA XENOGRAFT SS-2
VM MELANOMA XENCGRAFT MS-1
VN MELANOMA XENOCRAFT MS-2
VO MELANOMA XENOGRAFT MS-3
VP MELANCMA XENOGRAFT MS-4
VQ MELANCHA XENOGRAFT M5-5
VR MELANCMA XENOGRAFT M5-6
VS MELANCHA XENOGRAFT MS-7
VT MELANOMA XENOGRAFT MS-8
WA WALKER CARCINOSARCOMA 256 (SUBCUTANEOUS)
WC WALKER CARCINOMA/CYTOXAN; ASC 26271
WI HALKER CARCINOSARCOMA 256 (INTRAPERITONEAL) (SEE WA)
WM WALKER CARCINOSARCOMA 255 (INTRAMUSCULAR) (SEE WA)
WP WALKER CARCINOSARCOMA 255 (PULMONARY) (SEE LA)
XE ERLICH ASCITES TUMOR ENZYMES (BIOCHEMICAL ASSAY)
XL L1210 LEUKEMIA (BIOCHEMICAL ASSAY)
XM HUMAN LEUKEMIA CELL ENZYME (BIOCHEMICAL ASSAY)
XN HUMAN ERYTHROCYTE ENZYME (BICCHEMICAL ASSAY)
XR HUMAN ROC DIMOLE] (BIOCHEMICAL ASSAY)
XS HUMAN RBC CUNSPECIFIED] (BIOCHEMICAL ASSAY)
XX HUMAN RBC [BROKEN] (BIOCHEMICAL ASSAY)
XY HUMAN LIVER
YC MYELOID LEUKEMIA/ARA-C; NSC 63878 IN REM/UM MOUSE
10 COLON CYSTADEMOCARCINOMA 10/ A
11 COLON ADENOCARCIMOMA 11/A
12 COLON CYSTADENOCARCINOMA 12/A
13 C3H MAMMARY ADENOCARCINCMA 13/C
14 C3H MAMMARY ADENOCARCINOMA 14/C
16 C3H MAIM1ARY ADENOCARCINOMA 16/C
17 C3H MAMMARY ADENCCARCINCIA 17/C
18 C3H MAMMARY CYSTADENOCARCINOMA 18/C
2P PANCREATIC CARCINO1A 02
2R P338 LEUPEMIA/TIAZOFURIN; NSC 236193, DEVELOPED AT LMCB, DTP, DCT, NCI
2S P388 LEUKEMIA/SMETANTRONE, NSC 237513
2T P333 LEUKEMIA/ADRIAMYCIN; NSC 123127, DEVELOPED AT SCR 06 & 41
2U P328 LEUKEMIA/ADRIAMYCIN; NSC 123127, DEVELOPED AT SCR 01
2X P283 LYMPHOCYTIC LEUKEMIA/METHOTREXATE; NSC 740
23 C3H MAMMARY ADENOCARCINOMA 23/C
25 CARCINOMA: 1025
28 P288 LYMPHOCYTIC LEUKEMIA
4A 14946 LYMPHATIC LEUKENTA/AZASERINE: NSC 742
49 L4946 LYMPHATIC LEUKEMIA (SOLID)
5P P335 LEUKEMIA
6A COLON 06/A
6M L1210 LEUKEMIA/6-MP & 6-MMPR & 6-THIOGUANINE; NSC 755 NSC 40774, NSC NSC 752 
6T L1210 LEUKEMIAP6-THIOGUANINE; NSC 752
7A COLON 07/A
7P CA 755/6-MERCAPTOPURINE: NSC 755
8A COLON 03/A
8C PI79S/CORTISONE; NSC 9703
3P P1798 LYMPHOSARCOMA
8P P1798 LYMPHOSARCOMA *missing*
81 P1081 CHLOROLEUKEMIA
91 S-91 CLOUDMAN MELANOTIC MELANOMA 
98 C1498 MYELOID LEUKEMIA
